Table 1.

Clinical and EEG characteristics of the patients in the IGE and TLE groups.

Pt	Group center	Sex	Age (years)	Disease duration (years)	AEDs	Epilepsy type	Struct. MRI	IEDs
								Nb	Mean duration (s)	Side	Type and location
1	IGE Lille	M	13	9	LMG, VPA	Childhood absence epilepsy	N	20	1.8	–	GSW
2	IGE Lille	F	23	18	TPM, BZD	Juvenile myoclonic epilepsy	N	14	2.5	–	GSW
3	IGE Kiel	F	13	10	VPA, LTG, LEV	Myoclonic absence epilepsy	N	12	<1	–	GSW
4	IGE Kiel	M	6	1	VPA, TPM, LEV	Myoclonic absence epilepsy	N	12	<1	–	GSW
5	IGE Kiel	M	10	6	LTG, ESM	Childhood absence epilepsy	N	16	<1	–	GSW
6	IGE Kiel	M	5	1	LTG, ESM	Childhood absence epilepsy	N	17	2.5	–	GSW
7	TLE Lille	F	14	10	OXCBZ, TPM, VPA	Temporo-occipital	Temporo-occipital DNET	14	<1	Left	Temporo-occipital spikes
8	TLE Lille	F	20	17	LCM, BZD	Fronto-temporal	N	22	<1	Left	Fronto-temporal spikes
9	TLE Lille	F	45	15	OXCBZ, TPM, BZD	Temporo-perisylvian	N	14	<1	Left	Temporo-perisylvian rhythmic theta bursts
10	TLE Lille	F	33	14	LMG, TPM, LCM	Temporo-perisylvian	Temporo-insular dysplasia	14	<1	Left	Temporo-perisylvian spike and waves
11	TLE Lille	F	22	9	CBZ, LCM, ZNS, BZD	Temporo-occipital	N	12	2.4	left	Temporo-occipital polyspikes
12	TLE Lille	F	18	9	LMG, LVT, BZD	Temporal	N	10	<1	Left	Temporal spikes
Mean ± SD		18.5 ± 11.4	9.9 ± 5.5

Pt, patient; AEDs, antiepileptic drugs; OXCBZ, oxcarbazepine; TPM, topiramate; LMG, lamotrigine; VPA, valproate; LCM, lacosamide; LVT, levetiracetam; ZNS, zonisamide; BZD, benzodiazepin; ETSM, ethosuximide; IEDs, interictal epiletiform discharges; N, normal; GSW, generalized spike and waves; Nb, number; M, male; F, female; DNET, dysembryoplastic neuroepithelial tumor; Struc., structural.